PAULINE HEUSER: Open Payments
NPI 1134548456 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 27 payments from 14 companies in 2025. Trend: 2023 $1,363 · 2024 $975 · 2025 $760
Food & beverage: $562Education: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $216 |
| UCB, Inc. | 4 | $124 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $87 |
| Incyte Corporation | 2 | $55 |
| LEO Pharma Inc. | 3 | $49 |
| ABBVIE INC. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Galderma Laboratories, L.P. | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $27 |
Products named: TREMFYA, Bimzelx, OPZELURA, Winlevi, ANZUPGO, Leqselvi, Sotyktu, DUPIXENT.
Industry payments across NV — which companies pay providers there.
